Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04499924
Brief Title: Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal Cancer (MOUNTAINEER-02)

First Submitted : July 31, 2020
First Submitted that Met QC Criteria : July 31, 2020
First Posted : August 5, 2020

Last Update Submitted that Met QC Criteria : April 28, 2021
Last Update Posted : May 3, 2021